Baylor College of Medicine to Have Mesothelioma Program Headed by Dr. David Sugarbaker Dr. David Sugarbaker is one of the best-known names in the world of mesothelioma, and he is moving from his current position as the Chief of Thoracic Surgery at Brigham and Women’s Hospital in Boston to go to Baylor College of Medicine. While at Baylor’s Lung Institute, he will head up their new mesothelioma and lung disease program, which starts in July of 2014. According to Dr. Sugarbaker, the goal is to create the best mesothelioma program in the world as a means to help treat their patients with the best possible tools, techniques, and knowledge. Many who know of Dr. Sugarbaker’s career were surprised to learn that he would be leaving Brigham and Women’s Hospital, since he had been there since the 1970s and was somewhat of a fixture at the hospital. During that time, he was also maintaining his professorship at Harvard Medical School, also in Boston. The move will likely be quite a big change for the doctor, but it seems to be something he is welcoming. It gives him a chance to pursue his passion of helping patients who are suffering from mesothelioma. Dr. Sugarbaker was the pioneer of extrapleural pneumonectomy, which is one of the treatment options for patients who have mesothelioma and who see no other alternative to their treatment.
What Is the Baylor Lung Institute? As mentioned, Dr. Sugarbaker will be running the Baylor Lung Institute and the new program, which focuses on mesothelioma patients. His goal is to improve upon the types of treatment and to create a program that covers many different areas of treatment for mesothelioma. He wants to create a number of different types of departments that cover the various specialties in the field of mesothelioma, and feels he can do this by filling out and improving upon the already strong programs at the hospital. One of the areas he hopes to focus on is genomic research, which specialists feel can help to better personalized treatment for mesothelioma patients. The nature of the research should help the doctors to get a better understanding of just how asbestos is affecting patients at a genetic level and how that will in turn cause mesothelioma. Dr. Sugarbaker feels that the ability to create a new sort of program for treatment and research is a great opportunity, and he feels it will ultimately benefit the patients.
How Will the Patients Benefit? Of course, patients who are going to Baylor, as well as mesothelioma patients around the world, are likely wondering just what types of benefits Dr. Sugarbaker’s move can offer them. For those patients who go to Baylor, it means that they will have access to one of the best and most knowledgeable physicians in the field. Dr. Sugarbaker feels that he and his team will be capable of starting a program quickly and helping to encourage even faster research, which is ultimately helpful for the patients. Baylor stands behind him and wants to build the program as quickly as possible as well. Since Baylor is in Texas, there is a healthy competition between MD Anderson Cancer Center, which is really another benefit for the patients. With Dr. Sugarbaker coming to Baylor, it makes MD Anderson want to improve their own research efforts, and this is simply great news for cancer patients all around. Competition, as well as collaboration, is a great way to further research and break new ground when it comes to helping patients and actually making strides in mesothelioma and other cancer research. It is an exciting time for Baylor as well as for the patients who are dealing with mesothelioma. In time, the program hopes to find even better options for dealing with mesothelioma.